The Climate and Preventure (CAP) study was initiated in 2011 by Nicola Newton, Maree Teesson, Tim Slade and Patricia Conrod as a school-based prevention initiative targeting alcohol and drug use.
The overall aim is to evaluate the efficacy of the Climate Schools: Healthy Lifestyles program, the first online program to simultaneously target the Big 6 risk factors among adolescents.
In 2016, researchers from the National Drug and Alcohol Research Centre completed the Australian Government Department of Health funded ‘Guidelines on the management of co-occurring alcohol and other drug and mental health conditions in alcohol and other drug treatment settings (2
In consultation with NSW Health, this project is aims to develop an online portal, to improve access to evidence based e-Health treatment packages for co-occurring mental health and substance use problems.
Anxiety and alcohol use disorders are among the most prevalent and debilitating of mental health disorders, and commonly co-occur. This project aims to address crucial questions about when and how to intervene to prevent the onset and exacerbation of alcohol and anxiety comorbidity.
In recent years there has been growing attention on the use of crystal methamphetamine in Australia and the significant harms related to its use.
Young people with comorbid disorders frequently come to the attention of a diverse range of service systems (e.g., health, social welfare, educational, and criminal justice systems), and present a significant challenge to service providers.
In this study, we will undertake detailed analyses of the largest cross-national epidemiologic study of mental and substance use disorders ever conducted. The WHO World Mental Health Survey (WMHS) initiative is a massive, unique endeavour.
The current study will develop and pilot a personality-targeted mental health prevention program based on cognitive training tasks and delivered to adolescents at risk for developing a range of psychopathology.
This report was commissioned by the NSW Mental Health Drug and Alcohol Office (MHDAO) to summarise key components for consideration in developing a strategic, practical, coordinated and efficient approach to the clinical management of comorbid mental illness and substance use.